July 23rd 2024
Data from phase 2 of the SANS-UUI trial are expected to support an application to the FDA for approval of the device in patients with urge urinary incontinence.
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Guideline linked to reduction in urodynamics testing
February 28th 2018Researchers have reported an association with the release of the AUA/SUFU Adult Urodynamics Guideline and reduction of urodynamics performed for diagnosis of overactive bladder, stress urinary incontinence, and mixed urinary incontinence.
Sacral neuromodulation, botulinum show equal efficacy
November 14th 2017In patients with refractory urgency urinary incontinence (UUI), sacral neuromodulation (InterStim) and onabotulinumtoxinA (Botox) produce similar reductions in mean daily UUI episodes, according to 24-month follow-up data on patients treated in a randomized trial.
Female Urology: How dynamic MRI compares with physical exam for evaluating POP
July 13th 2017A study that found that age was more strongly associated with selection of colpocleisis than frailty and a comparison of two common wide pore polypropylene Y meshes were among the noteworthy female urology/incontinence research at the AUA annual meeting in Boston.
Urology, gynecology collaboration addresses rising demand
January 1st 2017In this interview, Sarah E. McAchran, MD, discusses the need for urology-gynecology collaboration, the background behind the ABMS recognizing the female pelvic medicine and reconstructive surgery subspecialty, and how barriers to full integration of providers treating pelvic floor disorders can be overcome.
Former Olympian Retton shares her struggle with OAB, launches educational campaign
May 24th 2005For most of her life, former Olympic gymnast Mary Lou Retton suffered from severe urgency and frequency related to overactive bladder. It wasn't until she consulted a urologist just over a year ago that Retton, now 37, received relief from her sometimes debilitating symptoms.Retton has gone public with her personal struggle in a campaign backed by Pfizer. She said she hopes her own experience will help others with the condition seek proper care.